RIXUBIS
These highlights do not include all the information needed to use RIXUBIS safely and effectively. See full prescribing information for RIXUBIS. RIXUBIS [Coagulation Factor IX (Recombinant)] For Intravenous Injection, Lyophilized Powder for Solution Initial U.S. Approval: 2013
f5070a92-96b8-476a-a2dc-18b22d95e5e0
PLASMA DERIVATIVE
Apr 7, 2025
Takeda Pharmaceuticals America, Inc.
DUNS: 039997266
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
COAGULATION FACTOR IX (RECOMBINANT)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
COAGULATION FACTOR IX (RECOMBINANT)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
COAGULATION FACTOR IX (RECOMBINANT)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
COAGULATION FACTOR IX (RECOMBINANT)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
COAGULATION FACTOR IX (RECOMBINANT)
Product Details
FDA regulatory identification and product classification information